Recent developments in the treatment of moderate-to-severe atopic dermatitis (AD) have changed the way in which we are able to manage the disease. This interactive case-based educational program allows you to meet 3 patients in an AD clinic, make management decisions, compare your responses with those of your peers, and learn from the experts about best management approaches.
Difficulty in addressing patients' concerns about their disease, impaired quality of life, and treatment desires; as well as difficulty in adequately including patients in the decision-making process, may all be contributing factors to the lack of adherence to prescribed treatment regimens, which is one of the greatest barriers in the treatment of atopic dermatitis (AD). New developments in the understanding of AD pathogenesis and novel treatment strategies that more successfully target the cause of the disease could help, but many clinicians are unaware of these recent changes. Additionally, discrepancies between allergic and dermatologic guidelines for treatment of AD results in inconsistent treatment of AD patients. Without appropriate and effective treatment, dermatitis may progress to allergic rhinitis and then asthma in the "atopic march".